Imunon

(NASDAQ) CLSN

Current PriceN/A

Market CapN/A

Since IPO (1995)-100%

5 Year-99%

1 Year-74%

1 Month-13%

Imunon Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$725.20K

Net Income (TTM)

$14.49M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

CLSN News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Imunon

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Stacy R. Lindborg, PhD

Website

imunon.com

Headquarters

Lawrence Township, NJ 08648, US

CLSN Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-4%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$14.65B

EBITDA

$14.65M

Operating Cash Flow

$13.90B

Capital Expenditure

$280.57M

Free Cash Flow

$14.18B

Cash & ST Invst.

$8.78M

Total Debt

$1.01M

Imunon Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$725.20K

-190.1%

Gross Profit

$362.60K

-45.0%

Gross Margin

50.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$10.26B

+155.2%

EBITDA

$2.76B

+114.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$7.77M

+100.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$602.00K

-99.9%

Short Term Debt

$406.00K

-99.9%

Return on Assets

-1.18%

N/A

Return on Invested Capital

-1.91%

N/A

Free Cash Flow

$5.51B

+129.2%

Operating Cash Flow

$4.98B

+126.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CYADCelyad Oncology S.A.

CYADCelyad Oncology S.A.$0.47-12.96%

SQZBSQZ Biotechnologies Company

SQZBSQZ Biotechnologies Company$0.02-0.41%

HURATuHURA Biosciences, Inc.

HURATuHURA Biosciences, Inc.$2.14-8.15%

TLPHTalphera, Inc.

TLPHTalphera, Inc.$0.89-3.06%

WENAAnew Medical, Inc.

WENAAnew Medical, Inc.$0.73-3.84%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.84+2.39%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

PLTRPalantir Technologies

PLTRPalantir Technologies$146.03+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.69-0.00%

SOFISoFi Technologies

SOFISoFi Technologies$16.20-0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.40+0.02%

Questions About CLSN

What is the current price of Imunon?

Imunon is trading at N/A per share.

What is the 52-week range for Imunon?

Over the past 52 weeks, Imunon has traded between N/A and N/A.

How much debt does Imunon have?

As of the most recent reporting period, Imunon reported total debt of $1.01M.

How much cash does Imunon have on hand?

Imunon reported $8.78M in cash and cash equivalents in its most recent financial results.

What is Imunon’s dividend yield?

Imunon does not currently have a dividend yield.

Imunon

Imunon Financials at a Glance

CLSN News

3 Biotech Stocks To Avoid

A Fool Looks Back

The Fool Looks Ahead

This Week in Biotech

3 Horrendous Health-Care Stocks This Week

Why Celsion Shares Were Eviscerated

Why Shares of Celsion Got Crushed Today

Celsion Collapses on Failure: What's Next?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Imunon

CLSN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Imunon Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CLSN

What is the current price of Imunon?

What is the 52-week range for Imunon?

How much debt does Imunon have?

How much cash does Imunon have on hand?

What is Imunon’s dividend yield?

Premium Investing Services